Zero-shot de novo peptide sequencing with open posttranslational modification discovery
peer-reviewed · Nature Biotechnology · 2026
| Date | 2026-05-19 |
| Type | peer-reviewed |
| Venue | Nature Biotechnology |
| Publisher | Springer Science and Business Media LLC |
| Contribution | algorithm |
| DOI | 10.1038/s41587-026-03116-1 |
| Citations (OpenAlex) | 2 |
| Venue 2-year citedness | 12.89 |
Preprint version: Zero-Shot De Novo Peptide Sequencing with Open Post-Translational Modification Discovery (2025-06-27, Research Square)
Abstract
De novo peptide sequencing directly infers sequences from mass spectrometry data without relying on protein databases. Although recent deep learning models can also identify posttranslational modifications (PTMs), they require labeled training data for this task. Here we introduce rotary positional embedding-enhanced de novo sequencing algorithm (RNovA), a transformer-based de novo sequencing algorithm enhanced with relative positional embeddings and a reinforcement-learning-style sequential decision framework. RNovA enables open PTM discovery in a zero-shot setting-without retraining or a predefined list of candidate residues-while maintaining state-of-the-art performance on standard benchmarks. Demonstrating this capability, we successfully identified peptides modified by kynurenine-an uncommon and biologically relevant PTM-in clinical samples from patients with RA and validated this discovery with synthetically synthesized reference peptides. Furthermore, we demonstrated open de novo PTM discovery by analyzing the bacterial strain A1232E, which lacks a reference proteome, and detected an unannotated glutamic acid modification. RNovA enables exploration of previously inaccessible regions of the proteome, including peptides with unexpected or unannotated modifications.
Methods and tools
- RNovA: Zero-shot open PTM discovery
Data deposited
- Zero-Shot De Novo Peptide Sequencing with Open Post-Translational Modification Discovery (as deposited) · PXD076296
Data used
- A quantitative and site-specific atlas of the PADI4-induced citrullinome reveals widespread existence of citrullination (as deposited) · PXD038702
- CHPP chr 1,8,20 proteome dataset using the HCC cell lines of Hep3B and MHCC97H, instrument is Q Exactive, part 2 of 3 (as deposited) · PXD000533
- CHPP chr 1,8,20 proteome dataset using the HCC cell lines of MHCC97H and HCCLM3, instrument is Q Exactive, part 1 of 3 (as deposited) · PXD000529
- ProteomeTools (21-PTM subset) · InstaDeepAI/PXD009449, PXD009449
Cites (10)
- InstaNovo enables diffusion-powered de novo peptide sequencing in large-scale proteomics experiments (2025) crossref
- π-PrimeNovo: an accurate and efficient non-autoregressive deep learning model for de novo peptide sequencing (2025) crossref
- NovoBoard: A Comprehensive Framework for Evaluating the False Discovery Rate and Accuracy of De Novo Peptide Sequencing (2024) crossref
- Accounting for Digestion Enzyme Bias in Casanovo (2024) crossref
- Mitigating the missing-fragmentation problem in de novo peptide sequencing with a two-stage graph-based deep learning model (2023) crossref
- Computationally instrument-resolution-independent de novo peptide sequencing for high-resolution devices (2021) crossref
- Deep Learning in Proteomics (2020) crossref
- De novo peptide sequencing by deep learning (2017) crossref
- Evaluating de novo sequencing in proteomics: already an accurate alternative to database-driven peptide identification? (2017) crossref
- PEAKS DB: De Novo Sequencing Assisted Database Search for Sensitive and Accurate Peptide Identification (2012) crossref